John P. Jakupciak

National Institute of Standards and Technology

Papers

Total Citations

H-Index

About

John P. Jakupciak has made foundational contributions to the early detection of cancer through the analytical validation of telomerase activity. His research focuses on developing and standardizing noninvasive, cost-effective clinical assays that measure telomerase—an enzyme reactivated in most cancers—in body fluids. His most cited work, “Analytical Validation of Telomerase Activity for Cancer Early Detection” (2004, 30 citations), established critical performance metrics for translating telomerase assays from the lab to the clinic. In a complementary study (2005, 18 citations), he led the preparation and characterization of candidate reference materials for telomerase assays, addressing a key barrier to reproducibility: the lack of standardized controls for the telomerase repeat amplification protocol (TRAP). By tackling both analytical validation and reference standards, Jakupciak’s work has directly enabled more reliable, scalable testing for early-stage malignancies. His contributions are particularly impactful for researchers and clinicians seeking robust biomarkers for cancer screening, and his efforts in assay standardization continue to influence the field of molecular diagnostics.